1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Global High Content Screening (HCS) Industry

Global High Content Screening (HCS) Industry

  • February 2016
  • -
  • Global Industry Analysts
  • -
  • 202 pages

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as -

BD Biosciences
BioTek Instruments Inc.
Definiens AG
EMD Millipore
Evotec AG

Table Of Contents

Global High Content Screening (HCS) Industry


I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation and Reporting Level I-2 Quantitative Techniques and Analytics I-3 Product Definitions and Scope of Study I-3 Consumables.............. I-3 Instrumentation.............. I-3 Others.............. I-4 Software.............. I-4 Services.............. I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 HCS - An Evolving Screening Technology II-1 HCS Market Ripe with Growth Opportunity II-2 Key Growth Drivers.............. II-3 Key Challenges.............. II-3 Market Outlook.............. II-3 Developing Regions Drive Future Growth II-4 Table 1: Global High Content Screening (HCS) Market - Geographic Regions Ranked by CAGR for 2014-2020 (includes corresponding Graph/Chart)..............II-4 HCS Software - A High Growth Market II-5 Equipment Sales Continue to Expand II-5 Recession in Pharma Industry Hits Prospects for Consumables and Instruments.............. II-5 Competitive Overview..............II-6 Focus on Key Players in the HCS Market II-6 BD Biosciences.............. II-6 Thermo Fisher Scientific Inc...............II-7 GE Healthcare.............. II-7 PerkinElmer Inc...............II-7 Table 2: Leading Players in the Global HCS Market (2015E): Percentage Share Breakdown for BD Biosciences, GE Healthcare, PerkinElmer, Molecular Devices, Thermo Fisher Scientific, Thorlabs, and Others (includes corresponding Graph/Chart).............. II-7 Venture Capital Investments Continue to Grow II-8

2. MARKET TRENDS AND ISSUES..............II-9 HCS - Evolves as Primary Screening Method II-9 Table 3: Global Screening Market (2014): Percentage Share Breakdown by Segment - Primary Screening, Secondary Screening and Leads-to-Candidate (ADME/Tox Screening) (includes corresponding Graph/Chart)..............II-9 Technology Advancements Spearhead Market Growth II-9 Government Support Bodes Well for the Market II-10 Emergence of Academic Sector as the Major User of HCS II-10 Table 4: HCS Budget of a Typical Research Company (includes corresponding Graph/Chart)..............II-11

Table 5: Global High-Throughput Screening Market (2015): Percentage Breakdown of Sales by End-use Segment (includes corresponding Graph/Chart)..............II-11 Stem Cell Biology - An Emerging Area of Interest II-11 HCS Specific Data Analysis Systems - The Need of the Hour II-12 HCS vs. HTS.............. II-13 Rise in Adoption of HCS Technology in HTS Laboratories II-13 Market Challenges.............. II-14 High Instrumentation Costs Hamper Rapid Growth II-14

3. PRODUCT OVERVIEW.............. II-15 Defining High Content Screening..............II-15 The Process of High Content Screening II-15 The Process of High Content Screening II-16 Technology Evolves Over the Years II-17 HCS Tools.............. II-17 List of HCS Tools..............II-17 HCS Imaging - Categories..............II-18 Instrumentation.............. II-18 Consumables.............. II-18 Software.............. II-18 Services.............. II-18

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-19 Molecular Devices Launches New ImageXpress® Micro Confocal HCS II-19 CYTOO Launches MyoScreen?™ Platform II-19 Molecular Devices Unveils EarlyTox™ Cell Viability Assay Kits II-19 Molecular Devices Introduces FLIPR® Potassium Assay Kit II-19 IntelliCyt Unveils iQue® Screener PLUS II-19 BioTek Launches Cytation™ 5 Cell Imaging Multi-Mode Reader II-19 Genedata Launches Genedata Screener® 12 II-19 Thermo Fisher Scientific Introduces New CeLLInsight CX5 HCS Platform.............. II-20 PerkinElmer Introduces Opera Phenix™ Next-Gen HCS System II-20 Molecular Devices Unveils ImageXpress® Micro XLS System II-20 TMO Unveils HCS Studio Software..............II-20 Molecular Devices Launches FLIPR® Calcium 6 Assay Kits II-20 TMO Expands its HCS Portfolio with Three New Products II-20 Cytoo Introduces 2D+ Solutions II-20 TTP Labtech Unveils Acumen High Content Imaging System II-20

5. RECENT INDUSTRY ACTIVITY..............II-21 Genedata Forms Alliance with IntelliCyt II-21 Harlan Inks Strategic Partnership with Fluofarma II-21 BioTech Inks Distribution Agreement with IDEA Bio-Medical II-21

6. FOCUS ON SELECT GLOBAL PLAYERS..............II-22 BD Biosciences (US).............. II-22 BioTek Instruments Inc. (US)..............II-22 Definiens AG (Germany)..............II-23 EMD Millipore (US)..............II-23 Evotec AG (Germany).............. II-24 Essen BioScience (US)..............II-24 Fluxion Biosciences, Inc. (US) II-25 GE Healthcare Life Sciences (Sweden) II-25 Genedata AG (Switzerland)..............II-25 IntelliCyt Corporation (US)..............II-26 Molecular Devices Inc. (US)..............II-26 PerkinElmer Inc. (US)..............II-26 Roche Applied Sciences (Germany) II-27 Thermo Fisher Scientific, Inc. (US) II-27 Thorlabs, Inc. (US).............. II-28 TTP LabTech Ltd. (UK)..............II-29 Yokogawa Electric Corporation (Japan) II-29

7. GLOBAL MARKET PERSPECTIVE..............II-30 Table 6: World Recent Past, Current and Future Analysis for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) II-30

Table 7: World Historic Review for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............II-31

Table 8: World 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart).............. II-32

Table 9: World Recent Past, Current and Future Analysis for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-33

Table 10: World Historic Review for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) II-34

Table 11: World 14-Year Perspective for High Content Screening by Segment - Percentage Breakdown of Revenues for Consumables, Instruments, and Others Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart) II-35

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Market Overview.............. III-1 Product Launches..............III-1 Recent Industry Activity..............III-3 Key Players.............. III-3 B.Market Analytics..............III-9 Table 12: US Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-9

Table 13: US Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-10

2. CANADA.............. III-11 Market Analysis.............. III-11 Table 14: Canadian Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-11

Table 15: Canadian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-12

3. JAPAN.............. III-13 A.Market Analysis.............. III-13 Outlook.............. III-13 Yokogawa Electric Corporation - A Key Player III-13 B.Market Analytics..............III-14 Table 16: Japanese Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-14

Table 17: Japanese Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-15

4. EUROPE.............. III-16 A.Market Analysis.............. III-16 Outlook.............. III-16 Clinical Trials Market in Europe III-16 B.Market Analytics..............III-17 Table 18: European Recent Past, Current and Future Analysis for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-17

Table 19: European Historic Review for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-18

Table 20: European 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............III-19

4a. FRANCE.............. III-20 A.Market Analysis.............. III-20 Outlook.............. III-20 Corporate Development..............III-20 Fluofarma SA - A Key Player..............III-20 B.Market Analytics..............III-21 Table 21: French Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-21

Table 22: French Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-22

4b. GERMANY.............. III-23 A.Market Analysis.............. III-23 Outlook.............. III-23 Key Players.............. III-23 B.Market Analytics..............III-24 Table 23: German Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-24

Table 24: German Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-25

4c. ITALY.............. III-26 A.Market Analysis.............. III-26 Outlook.............. III-26 B.Market Analytics..............III-26 Table 25: Italian Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-26

Table 26: Italian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-27

4d. THE UNITED KINGDOM..............III-28 A.Market Analysis.............. III-28 Outlook.............. III-28 Product Launch.............. III-28 Key Players.............. III-28 B.Market Analytics..............III-29 Table 27: The UK Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-29

Table 28: The UK Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-30

4e. SPAIN.............. III-31 A.Market Analysis.............. III-31 Outlook.............. III-31 B.Market Analytics..............III-31 Table 29: Spanish Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-31

Table 30: Spanish Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-32

4f. REST OF EUROPE.............. III-33 A.Market Analysis.............. III-33 Outlook.............. III-33 Product Launch.............. III-33 Strategic Corporate Development III-33 Key Players.............. III-33 B.Market Analytics..............III-35 Table 31: Rest of Europe Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-35

Table 32: Rest of Europe Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-36

5. ASIA-PACIFIC.............. III-37 A.Market Analysis.............. III-37 Outlook.............. III-37 Select Regional Analysis..............III-37 China.............. III-37 China Emerges as the Major Outsourcer for Drug Discovery III-37 India.............. III-38 B.Market Analytics..............III-39 Table 33: Asia-Pacific Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-39

Table 34: Asia-Pacific Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-40

6. REST OF WORLD.............. III-41 Market Analysis.............. III-41 Table 35: Rest of World Recent Past, Current and Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-41

Table 36: Rest of World Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-42

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 73 (including Divisions/Subsidiaries - 80)

The United States (36) Japan (3) Europe (36) - France (6) - Germany (9) - The United Kingdom (10) - Italy (1) - Spain (1) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (3) Middle East (2)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.